Acemi respondió a informes de Adres sobre medicamentos y atención médica, en medio del debate por ajuste a la UPC

Acemi has questioned the rigor of the audits conducted by Adres on payments to deceased individuals and the supply of medications, arguing that the inconsistencies identified are largely the result of administrative delays and regulatory changes, rather than irregularities. This argument underscores the critical need for transparent methodologies and due processes that enable data validation prior to any dissemination, thereby safeguarding the integrity and trust in the healthcare system. The association also warns about the risks associated with the release of sensitive data, emphasizing the importance of ensuring confidentiality and anonymity to prevent misinterpretations or reputational harm. By demanding access to anonymized information, it promotes a balance between the transparency required by citizens and the protection of patient privacy—a fundamental principle in the ethical management of health information. This debate is relevant to open data because it illustrates the technical and ethical challenges involved in publishing government datasets. It demonstrates that the mere availability of information does not guarantee its usefulness or fairness; rather, it requires context, normalization, and procedural safeguards to be truly valuable for public analysis and accountability.

Source: portafolio.co
Published on 2025-12-20

Acemi respondió a informes de Adres sobre medicamentos y atención médica, en medio del debate por ajuste a la UPC

Related news